drugset / Trial / NCT01690949

Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers

NCT01690949 ↗

Phase 1 Completed 24 enrolled Pulmatrix Inc.
RandomizedCrossoverSingle-blindTreatment

Summary

This trial in healthy subjects will assess PUR118's effect on attenuating ozone induced airway inflammation. This trial will establish the tolerability of PUR118 in healthy normal volunteers.

Timeline

Start
2012-08
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject PUR118 Unknown 2.8 mg Inhaled
Subject PUR118 Unknown 5.5 mg Inhaled
Subject PUR118 Unknown 11 mg Inhaled